Nektar Therapeutics
USD69.69
+4.30 (+6.58%)
CEO
Howard W. Robin
IPO Date
1994-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$66.39
Prev. Close
$65.39
Day Low
$66.33
Day High
$71.50
52W Low
$21.02
52W High
$109.00
Market Cap
$1.36B
Volume
1.06M
| 4,697 |
| $60.71 |
| 18 Jun 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 5,500 | $60.81 |
| 18 Jun 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 4,500 | $61.65 |
| 17 Jun 2026 | Zalevsky Jonathan | Chief R&D Officer | S-Sale | Disposed | 5,538 | $60.71 |
| 26 May 2026 | Rubinstein Linda M | — | Disposed | 0 | $0.00 |
| 21 May 2026 | Zalevsky Jonathan | Chief R&D Officer | S-Sale | Disposed | 199 | $65.51 |
| 21 May 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 444 | $65.51 |
| 20 Feb 2026 | Zalevsky Jonathan | Chief R&D Officer | S-Sale | Disposed | 180 | $73.00 |
| 20 Feb 2026 | ROBIN HOWARD W | director, officer: President & CEO | S-Sale | Disposed | 423 | $73.00 |